164 related articles for article (PubMed ID: 7943186)
1. Latent Epstein-Barr virus infection in cottontop tamarins. A possible model for Epstein-Barr virus infection in humans.
Niedobitek G; Agathanggelou A; Finerty S; Tierney R; Watkins P; Jones EL; Morgan A; Young LS; Rooney N
Am J Pathol; 1994 Oct; 145(4):969-78. PubMed ID: 7943186
[TBL] [Abstract][Full Text] [Related]
2. Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vector.
Finerty S; Tarlton J; Mackett M; Conway M; Arrand JR; Watkins PE; Morgan AJ
J Gen Virol; 1992 Feb; 73 ( Pt 2)():449-53. PubMed ID: 1311367
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
4. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
5. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
6. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
7. Prevention of Epstein-Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes.
Morgan AJ; Finerty S; Lovgren K; Scullion FT; Morein B
J Gen Virol; 1988 Aug; 69 ( Pt 8)():2093-6. PubMed ID: 2841417
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
[TBL] [Abstract][Full Text] [Related]
9. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells.
Niedobitek G; Agathanggelou A; Herbst H; Whitehead L; Wright DH; Young LS
J Pathol; 1997 Jun; 182(2):151-9. PubMed ID: 9274524
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
12. Vaccination against herpesvirus, fiction or reality?
Morein B; Merza M
Scand J Infect Dis Suppl; 1991; 80():110-8. PubMed ID: 1666442
[TBL] [Abstract][Full Text] [Related]
13. Immunisation of common marmosets with vaccinia virus expressing Epstein-Barr virus (EBV) gp340 and challenge with EBV.
Mackett M; Cox C; Pepper SD; Lees JF; Naylor BA; Wedderburn N; Arrand JR
J Med Virol; 1996 Nov; 50(3):263-71. PubMed ID: 8923292
[TBL] [Abstract][Full Text] [Related]
14. Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma.
Araujo I; Foss HD; Hummel M; Anagnostopoulos I; Barbosa HS; Bittencourt A; Stein H
J Pathol; 1999 Feb; 187(3):326-30. PubMed ID: 10398087
[TBL] [Abstract][Full Text] [Related]
15. Expression of viral and human dUTPase in Epstein-Barr virus-associated diseases.
Fleischmann J; Kremmer E; Greenspan JS; Grässer FA; Niedobitek G
J Med Virol; 2002 Dec; 68(4):568-73. PubMed ID: 12376965
[TBL] [Abstract][Full Text] [Related]
16. Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin.
Ragot T; Finerty S; Watkins PE; Perricaudet M; Morgan AJ
J Gen Virol; 1993 Mar; 74 ( Pt 3)():501-7. PubMed ID: 8383183
[TBL] [Abstract][Full Text] [Related]
17. Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection.
Barletta JM; Kingma DW; Ling Y; Charache P; Mann RB; Ambinder RF
Mol Cell Probes; 1993 Apr; 7(2):105-9. PubMed ID: 8391639
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin's disease and peripheral T-cell lymphoma: composite lymphoma with evidence of Epstein-Barr virus infection.
Niedobitek G; Baumann I; Brabletz T; Lisner R; Winkelmann C; Helm G; Kirchner T
J Pathol; 2000 Aug; 191(4):394-9. PubMed ID: 10918214
[TBL] [Abstract][Full Text] [Related]
19. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC
Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774
[TBL] [Abstract][Full Text] [Related]
20. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis.
Takashima K; Ohashi M; Kitamura Y; Ando K; Nagashima K; Sugihara H; Okuno K; Sairenji T; Hayashi K
J Med Virol; 2008 Mar; 80(3):455-66. PubMed ID: 18205213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
